S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
The Incredible Dividend Map... Where Stocks Yield 26% a Year! (Ad)pixel
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
New $2.2 Quadrillion Trend About To Open Up (Ad)pixel
NASDAQ:ZIMV

ZimVie - ZIMV Stock Forecast, Price & News

$19.34
-0.48 (-2.42%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$19.22
$19.93
50-Day Range
$15.88
$22.14
52-Week Range
$14.94
$50.40
Volume
138,156 shs
Average Volume
429,883 shs
Market Capitalization
$504.39 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$20.00

ZimVie MarketRank™ Forecast

Analyst Rating
Hold
1.67 Rating Score
Upside/​Downside
39.6% Upside
$27.00 Price Target
Short Interest
Bearish
5.24% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.05mentions of ZimVie in the last 14 days
Based on 3 Articles This Week
Insider Trading
Acquiring Shares
$200,400 Bought Last Quarter
Proj. Earnings Growth
4.09%
From $2.20 to $2.29 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

Medical Sector

830th out of 1,098 stocks

Dental Equipment & Supplies Industry

5th out of 6 stocks

ZIMV stock logo

About ZimVie (NASDAQ:ZIMV) Stock

ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral scanners, as well as spinal fusion implants and instrumentation for various spinal procedures, biologics, and bone healing technologies. The company also provides MIS solutions, such as Vital MIS and Timberline; and motion preservation solutions, including Mobi-C and The Tether. ZimVie Inc. was incorporated in 2021 and is headquartered in Westminster, Colorado.

ZimVie Trading Down 1.9 %

Shares of ZimVie stock traded down $0.38 during trading on Tuesday, hitting $19.44. The stock had a trading volume of 1 shares, compared to its average volume of 168,104. The company has a quick ratio of 1.41, a current ratio of 2.50 and a debt-to-equity ratio of 0.72. The firm's fifty day simple moving average is $18.32. ZimVie has a fifty-two week low of $14.94 and a fifty-two week high of $50.40.

Analyst Ratings Changes

Separately, JPMorgan Chase & Co. started coverage on ZimVie in a report on Friday, June 17th. They set a "neutral" rating and a $20.00 price objective on the stock.

Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Stock News Headlines

ZimVie: Undervalued Spin-Off
ZimVie launches 2 dental solutions in US
ZimVie Inc. Tops Q1 EPS by 8c
ZimVie Inc.
See More Headlines
Receive ZIMV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ZimVie and its competitors with MarketBeat's FREE daily newsletter.

ZIMV Company Calendar

Today
8/09/2022
Next Earnings (Confirmed)
8/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Dental equipment & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ZIMV
Fax
N/A
Employees
2,700
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$27.00
High Stock Price Forecast
$34.00
Low Stock Price Forecast
$20.00
Forecasted Upside/Downside
+3.4%
Consensus Rating
Hold
Rating Score (0-4)
1.67
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$1.01 billion

Miscellaneous

Free Float
N/A
Market Cap
$504.39 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Vafa Jamali (Age 51)
    Pres, CEO & Director
    Comp: $1.61M
  • Mr. Richard J. Heppenstall (Age 51)
    Exec. VP, CFO & Treasurer
    Comp: $690.25k
  • Ms. Heather Kidwell (Age 53)
    Sr. VP, Chief Legal & Compliance Officer and Corp. Sec.
    Comp: $460.18k
  • Mr. Indraneel Kanaglekar (Age 44)
    Sr. VP & Pres of Global Dental
    Comp: $575.57k
  • Ms. Rebecca A. Whitney (Age 45)
    Sr. VP & Pres of Global Spine
    Comp: $580.64k
  • Mr. Benjamin Hutson
    Sr. VP of Operations
  • Sandra Schneider
    Chief Accounting Officer
  • Mr. Steve Rondeau
    Sr. VP & Chief Information Officer
  • Ms. Laura Driscoll
    VP of Communications
  • Mr. Michael Minette
    Sr. VP of Strategy & Corp. Devel.













ZIMV Stock - Frequently Asked Questions

Should I buy or sell ZimVie stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for ZimVie in the last year. There are currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" ZIMV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ZIMV, but not buy additional shares or sell existing shares.
View ZIMV analyst ratings
or view top-rated stocks.

What is ZimVie's stock price forecast for 2022?

3 Wall Street research analysts have issued 12-month price objectives for ZimVie's shares. Their ZIMV share price forecasts range from $20.00 to $34.00. On average, they expect the company's stock price to reach $27.00 in the next year. This suggests a possible upside of 39.6% from the stock's current price.
View analysts price targets for ZIMV
or view top-rated stocks among Wall Street analysts.

How has ZimVie's stock price performed in 2022?

ZimVie's stock was trading at $25.53 at the beginning of 2022. Since then, ZIMV stock has decreased by 24.2% and is now trading at $19.34.
View the best growth stocks for 2022 here
.

When is ZimVie's next earnings date?

ZimVie is scheduled to release its next quarterly earnings announcement on Wednesday, August 10th 2022.
View our ZIMV earnings forecast
.

How can I listen to ZimVie's earnings call?

ZimVie will be holding an earnings conference call on Wednesday, August 10th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link.

What guidance has ZimVie issued on next quarter's earnings?

ZimVie updated its FY 2022 earnings guidance on Monday, May, 30th. The company provided earnings per share (EPS) guidance of $2.10-$2.30 for the period, compared to the consensus estimate of $2.16. The company issued revenue guidance of $1.00 billion-$1.00 billion, compared to the consensus revenue estimate of $992.90 million.

What is ZimVie's stock symbol?

ZimVie trades on the NASDAQ under the ticker symbol "ZIMV."

How do I buy shares of ZimVie?

Shares of ZIMV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is ZimVie's stock price today?

One share of ZIMV stock can currently be purchased for approximately $19.34.

How much money does ZimVie make?

ZimVie (NASDAQ:ZIMV) has a market capitalization of $504.39 million and generates $1.01 billion in revenue each year.

How many employees does ZimVie have?

ZimVie employs 2,700 workers across the globe.

How can I contact ZimVie?

The official website for the company is www.zimvie.com. The company can be reached via phone at 303-443-7500 or via email at marissa@gilmartinir.com.

This page (NASDAQ:ZIMV) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.